US Broker Ratings

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Exploring a Compelling 10.27% Potential Upside

Kymera Therapeutics, Inc. (KYMR), a healthcare standout in the biotechnology industry, has been attracting significant investor interest recently. With a market capitalization of $4.33 billion, this clinical-stage biopharmaceutical company is..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Potential 99% Upside

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage immunology company, is drawing significant interest from investors, primarily due to its promising pipeline of monoclonal antibodies aimed at treating various autoimmune diseases. As..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Exploring a $4.82 Billion Biotech’s Growth Trajectory and Analyst Confidence

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is making waves in the biotechnology sector with its innovative approach to peptide therapeutics. Headquartered in Newark, California, this biopharmaceutical company is focused on developing..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating the 12.26% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) stands as a significant player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Laval, Canada, Bausch Health..

NovoCure Limited (NVCR) Stock Analysis: Exploring an 86% Potential Upside in the Innovative Oncology Space

For investors eyeing the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents an intriguing opportunity. As a prominent player in the medical devices industry, NovoCure focuses on pioneering oncology treatments, particularly..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Biotech Powerhouse with 42% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company based in the United Kingdom, is making waves in the healthcare sector with its innovative approach to drug discovery and development...

LeMaitre Vascular, Inc. (LMAT): Investor Outlook on a 18.88% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) continues to draw attention within the healthcare sector, particularly in the medical instruments and supplies industry, as investors take note of its promising growth potential..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unpacking a 52% Potential Upside Amid Cutting-Edge Biotech Innovations

Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing investor attention with its promising pipeline of precision genetic medicines, reflected in a substantial potential upside of 52.24%. The company’s market capitalization stands..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 43.91% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a key player in the healthcare sector, has been capturing investor attention with a compelling story in the fertility and family building solutions market. As a..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 53% Potential Upside in Healthcare Innovation

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, specializes in medical devices designed to provide differentiated clinical solutions. Headquartered in Wilmington, Delaware, Enovis has carved a niche..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Reveals 150% Potential Upside Amidst Strong Buy Consensus

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is making waves in the biotechnology sector, capturing investor attention with its robust pipeline and a striking 150.15% potential upside on its stock price. As..

Privia Health Group, Inc. (PRVA) Stock Analysis: 14.90% Potential Upside Beckons Investors

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, emerging as a strong contender for investors seeking growth in the health information services industry. With a..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 134.92% Potential Upside in the Biotech Arena

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is making waves in the biotechnology sector with its innovative approach to treating muscle disorders. With a market capitalization of $1.62 billion, this Boulder, Colorado-based..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a Niche with Strategic Collaborations and a Robust Pipeline

PTC Therapeutics, Inc. (NASDAQ: PTCT), a key player in the biotechnology sector, extends its influence in the healthcare industry by addressing rare disorders. With its headquarters in Warren, New Jersey,..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Navigating a 33.67% Potential Upside Amidst Industry Challenges

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) operates at the intersection of healthcare and technology, providing innovative solutions for diabetes management. With a market capitalization of $1.05 billion, Tandem is a..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring an 83% Potential Upside with Promising Biotech Innovations

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology firm, is making waves in the healthcare sector with its pioneering approach to immunotherapies. With a market capitalization of $1.71 billion, Immunocore..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Biotech Play with 11.95% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is making waves in the biotechnology sector with its ambitious focus on dermatological treatments. The company’s innovative approach and impressive product pipeline have caught the..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 61.5% Upside Potential in the Mental Health Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is capturing investor attention with its promising 61.5% potential upside, driven by its strategic positioning in the burgeoning mental health sector. Headquartered in Scottsdale,..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 6.34% Potential Upside in the Medical Instruments Sector

Envista Holdings Corporation (NYSE: NVST), a formidable player in the healthcare sector, is capturing the attention of investors with its promising growth prospects and strategic positioning in the medical instruments..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges with a Healthcare Pivot

Investors eyeing opportunities in the healthcare sector might find BGM Group Ltd. (BGM) an intriguing yet challenging prospect. This Chengdu-based company, with a market capitalization of $1.84 billion, operates within..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds